JP5557416B2 - 原発性頭痛を抑制するための投与剤形 - Google Patents
原発性頭痛を抑制するための投与剤形 Download PDFInfo
- Publication number
- JP5557416B2 JP5557416B2 JP2006543505A JP2006543505A JP5557416B2 JP 5557416 B2 JP5557416 B2 JP 5557416B2 JP 2006543505 A JP2006543505 A JP 2006543505A JP 2006543505 A JP2006543505 A JP 2006543505A JP 5557416 B2 JP5557416 B2 JP 5557416B2
- Authority
- JP
- Japan
- Prior art keywords
- dosage form
- layer
- lidocaine
- hydrophilic polymer
- active ingredient
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7084—Transdermal patches having a drug layer or reservoir, and one or more separate drug-free skin-adhesive layers, e.g. between drug reservoir and skin, or surrounding the drug reservoir; Liquid-filled reservoir patches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0043—Nose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7007—Drug-containing films, membranes or sheets
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P23/00—Anaesthetics
- A61P23/02—Local anaesthetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Dermatology (AREA)
- Pain & Pain Management (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Anesthesiology (AREA)
- Otolaryngology (AREA)
- Rheumatology (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Description
ビノパール(Winopal)(ドイツ国)のTA.XT2iテクスチャー分析器を引裂強度の測定のために用いた。本発明の投与剤形のフィルム断片(長さ9.5cm、幅1cm)の両端を取付け具(clamping jaws)で取付け、そして、無張力時の長さ(free tension length)が7cmとなるようにわずかに伸ばした。この取付け具は、この断片が取付け部位で測定前に裂けることを避けるために、この断片と接触するようになる表面をコーテングして供給される。もしこの断片が取付け具のコーテングにもかかわらず裂けたとしたら、その値は考慮に入れない。上部の取付け具は一定の0.5mm/秒という速度で上方に引っ張り上げられる。この力はこの間の全時点において働いており、結果として伸びを生じ、テクスチャー分析器によって記録される。ついで、この力、伸びおよび時間が表示され、そしてソフトウエアを用いて解析される。
このようにして製造される投与剤形は柔軟性を有しそして容易に取り扱えた。
Claims (11)
- 架橋親水性重合体を基礎とする少なくとも1つの層中に、活性成分としてリドカインを含有し、そして医薬投与剤形が少なくとも40Nの引裂強度を有する、経鼻的に投与することができフィルム形である生体接着性の医薬投与剤形であって、リドカインの濃度がリドカイン含有層中の架橋親水性重合体の総量に対して30質量%〜60質量%であり、セルロースエーテルが架橋親水性重合体として使用され、そして活性成分含有層の親水性重合体がこの層の形成中に架橋され、ここで親水性重合体と架橋剤との比率は質量で2:1〜5:1であることを特徴とする医薬投与剤形。
- 少なくとも50Nの引裂強度を有することを特徴とする、請求項1に記載の投与剤形。
- セルロースエーテルが、ヒドロキシエチルセルロース、メチルセルロース、ヒドロキシプロピルセルロースおよび/またはヒドロキシプロピルメチルセルロースからなる群より選択されることを特徴とする、請求項1または2に記載の投与剤形。
- リドカインの制御された放出を示すことを特徴とする、請求項1〜3のいずれかに記載の投与剤形。
- 単層または多層であることを特徴とする、請求項1〜4のいずれかに記載の投与剤形。
- 少なくとも1つの活性成分含有層、1つの被覆層および/または1つの接着層を有することを特徴とする、請求項5に記載の投与剤形。
- 1つの活性成分含有層が接着層であることを特徴とする、請求項6に記載の投与剤形。
- 被覆層が活性成分に対して不浸透性であることを特徴とする、請求項6または7に記載の投与剤形。
- 経鼻的に投与できヒトの原発性頭痛を抑制するためのフィルム形の単層性または多層性で、少なくとも40Nの引裂強度を有する医薬投与剤形の製造のための、リドカインを30質量%〜60質量%含有する架橋親水性重合体を基礎とする、フィルム形の1つのリドカイン含有層の使用であって、セルロースエーテルが架橋親水性重合体として使用され、そしてリドカイン含有層の親水性重合体がこの層の形成中に架橋され、ここで親水性重合体と架橋剤との比率は質量で2:1〜5:1であることを特徴とする使用。
- 神経血管痛を抑制するための、請求項9に記載の使用。
- 片頭痛を抑制するための、請求項9に記載の使用。
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE10358749.7 | 2003-12-12 | ||
DE10358749A DE10358749A1 (de) | 2003-12-12 | 2003-12-12 | Darreichungsform zur Bekämpfung von primären Kopfschmerzen |
PCT/EP2004/014148 WO2005055977A2 (de) | 2003-12-12 | 2004-12-13 | Darreichungsform zur bekämpfung vom primären kopfschmerzen |
Publications (3)
Publication Number | Publication Date |
---|---|
JP2007513918A JP2007513918A (ja) | 2007-05-31 |
JP2007513918A5 JP2007513918A5 (ja) | 2012-08-30 |
JP5557416B2 true JP5557416B2 (ja) | 2014-07-23 |
Family
ID=34672770
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2006543505A Expired - Fee Related JP5557416B2 (ja) | 2003-12-12 | 2004-12-13 | 原発性頭痛を抑制するための投与剤形 |
Country Status (7)
Country | Link |
---|---|
US (1) | US7998503B2 (ja) |
EP (1) | EP1691794A2 (ja) |
JP (1) | JP5557416B2 (ja) |
CN (1) | CN1905862B (ja) |
CA (1) | CA2542256C (ja) |
DE (1) | DE10358749A1 (ja) |
WO (1) | WO2005055977A2 (ja) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8142592B2 (en) | 2008-10-02 | 2012-03-27 | Mylan Inc. | Method for making a multilayer adhesive laminate |
EP3912622A1 (en) | 2020-05-19 | 2021-11-24 | tesa Labtec GmbH | Oral film for safe administration of api |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6217911B1 (en) * | 1995-05-22 | 2001-04-17 | The United States Of America As Represented By The Secretary Of The Army | sustained release non-steroidal, anti-inflammatory and lidocaine PLGA microspheres |
US5081157A (en) * | 1988-05-02 | 1992-01-14 | Zila Pharmaceuticals, Inc. | Compositions and in situ methods for forming films on body tissue |
US5120544A (en) * | 1989-06-19 | 1992-06-09 | Henley International, Inc. | Crosslinked hydrogel and method for making same |
US5210544A (en) * | 1991-10-31 | 1993-05-11 | Universal Antenna Manufacturing, Inc. | Mounting means for an antenna installation |
WO1997011681A1 (en) * | 1995-09-29 | 1997-04-03 | Lam Pharmaceuticals Inc. | Sustained release delivery system and long acting narcotic analgesics and antagonists |
US5906814A (en) * | 1995-12-07 | 1999-05-25 | The Andrew Jergens Company | Topical film-forming compositions |
FR2742989B1 (fr) * | 1995-12-29 | 1998-01-23 | Adir | Composition pharmaceutique bioadhesive pour la liberation controlee de principes actifs |
US6432986B2 (en) * | 1997-07-21 | 2002-08-13 | Bruce H. Levin | Compositions, kits, and methods for inhibiting cerebral neurovascular disorders and muscular headaches |
US5989535A (en) * | 1997-08-15 | 1999-11-23 | Soma Technologies | Polymeric bioadhesive emulsions and suspensions and methods of treatment |
DE19932603A1 (de) * | 1999-07-13 | 2001-01-25 | Gruenenthal Gmbh | Wirkstoffhaltiger Mehrschichtfilm aus in situ vernetzten hydrophilen Polymeren |
AU2100901A (en) * | 1999-12-15 | 2001-06-25 | Bruce H. Levin | Compositions, kits, apparatus, and methods for inhibiting cephalic inflammation |
JP2003525895A (ja) * | 2000-03-09 | 2003-09-02 | アストラゼネカ・アクチエボラーグ | 固形分散剤の製造方法 |
DE10035865C2 (de) * | 2000-07-24 | 2003-02-06 | Norbert Over | Verwendung von wässrigen Spraylösungen des lokalanästhetischen Mittels Lidocain zur prophylaktischen Behandlung von Migräne |
DE10146251A1 (de) | 2001-09-20 | 2003-04-17 | Gruenenthal Gmbh | Vorrichtung zur Herstellung eines pharmazeutischen Films |
-
2003
- 2003-12-12 DE DE10358749A patent/DE10358749A1/de not_active Withdrawn
-
2004
- 2004-12-13 WO PCT/EP2004/014148 patent/WO2005055977A2/de active Application Filing
- 2004-12-13 CN CN2004800318875A patent/CN1905862B/zh not_active Expired - Fee Related
- 2004-12-13 EP EP04803785A patent/EP1691794A2/de not_active Withdrawn
- 2004-12-13 US US10/596,200 patent/US7998503B2/en not_active Expired - Fee Related
- 2004-12-13 CA CA2542256A patent/CA2542256C/en not_active Expired - Fee Related
- 2004-12-13 JP JP2006543505A patent/JP5557416B2/ja not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
CN1905862B (zh) | 2012-12-12 |
WO2005055977A2 (de) | 2005-06-23 |
EP1691794A2 (de) | 2006-08-23 |
CA2542256C (en) | 2012-10-16 |
JP2007513918A (ja) | 2007-05-31 |
WO2005055977A3 (de) | 2005-09-15 |
CA2542256A1 (en) | 2005-06-23 |
US20070086955A1 (en) | 2007-04-19 |
DE10358749A1 (de) | 2005-07-14 |
CN1905862A (zh) | 2007-01-31 |
US7998503B2 (en) | 2011-08-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP2791317B2 (ja) | 多層フィルム製剤 | |
AU2002365961B2 (en) | Micronized film-forming powder comprising an active substance | |
RU2343903C2 (ru) | Мукоадгезивное разрушимое устройство доставки лекарств для контролируемого введения фармацевтических препаратов и других активных соединений | |
KR100602403B1 (ko) | 구강 접착 쉬트 및 구강 접착 제제 | |
JPH0374205B2 (ja) | ||
CA2889452C (en) | Compositions and methods for transdermal delivery of amphetamine | |
NZ314009A (en) | Bioadhesive controlled release compositions comprising vinyl acetate/polyvinylpyrrolidone copolymers | |
WO2004110445A1 (ja) | フェンタニル含有口腔粘膜貼付剤 | |
Ponchel | Formulation of oral mucosal drug delivery systems for the systemic delivery of bioactive materials | |
KR100794264B1 (ko) | 구강 점막 투여용 다중 약물 제형 | |
JPS62135417A (ja) | フイルム状製剤 | |
CN114845700A (zh) | Otf的可溶性背衬层 | |
Hassan et al. | Formulation and in vitro/in vivo evaluation of naproxen mucoadhesive buccal patches for local effect | |
JP5557416B2 (ja) | 原発性頭痛を抑制するための投与剤形 | |
US20150190349A1 (en) | Transdermal therapeutic system | |
US11491107B2 (en) | Mucoadhesive preparations, methods and applications thereof | |
US20240156727A1 (en) | Rolled oral thin films having a high level of active-ingredient loading | |
CA3051159C (en) | Structured orodispersible films | |
Garg et al. | Buccal Bioadhesive Drug Delivery Systems and Their Applications | |
Paul et al. | EXPLORING THE POTENTIAL OF FAST DISSOLVING ORAL FILMS | |
Ratnakar et al. | Design of a novel buccoadhesive system for unidirectional release of valsartan | |
JPS6368523A (ja) | 外用貼付製剤 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20070906 |
|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20070906 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20110104 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20110323 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20111025 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20120125 |
|
A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20120201 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20120214 |
|
A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20120313 |
|
A524 | Written submission of copy of amendment under article 19 pct |
Free format text: JAPANESE INTERMEDIATE CODE: A524 Effective date: 20120706 |
|
A911 | Transfer to examiner for re-examination before appeal (zenchi) |
Free format text: JAPANESE INTERMEDIATE CODE: A911 Effective date: 20120720 |
|
A912 | Re-examination (zenchi) completed and case transferred to appeal board |
Free format text: JAPANESE INTERMEDIATE CODE: A912 Effective date: 20120810 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20140603 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 5557416 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
LAPS | Cancellation because of no payment of annual fees |